Nurse Practitioner, Family · Autaugaville, AL
NPI
1952799371
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
201 S Washington St
Autaugaville, AL, 36003
Phone (334) 361-9979
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.0M
7,666 prescriptions
Company payments, 2025
$876
From 18 companies
Medicare prescription drug claims, 2024
In 2024, the drug Diana L Kenyon prescribed most often to Medicare patients was Atorvastatin Calcium, with 384 prescriptions and refills. In total Diana L Kenyon wrote 7,666 Medicare prescriptions that cost $1.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 384 | 813 | 96 | $5,285 |
| Amlodipine Besylate Generic | 254 | 552 | 70 | $2,179 |
| Montelukast Sodium Generic | 248 | 484 | 59 | $3,422 |
| Pantoprazole Sodium Generic | 247 | 456 | 68 | $3,069 |
| Levothyroxine Sodium Generic | 223 | 406 | 43 | $2,587 |
| Omeprazole Generic | 194 | 387 | 50 | $3,166 |
| Metformin Hcl Generic | 174 | 375 | 51 | $1,076 |
| Cyproheptadine Hcl Generic | 160 | 167 | 23 | $2,996 |
| Azithromycin Generic | 159 | 159 | 107 | $666 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 156 | 191 | 51 | $5,379 |
| Fluticasone Propionate Generic | 147 | 180 | 54 | $2,696 |
| Levocetirizine Dihydrochloride Generic | 147 | 295 | 40 | $1,887 |
| Furosemide Generic | 145 | 262 | 54 | $684 |
| Farxiga Dapagliflozin Propanediol | 137 | 220 | 38 | $125K |
| Famotidine Generic | 134 | 307 | 45 | $2,620 |
Brand drugs: 1,151 claims; generic drugs: 6,472 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diana L Kenyon $876 ($876 in general payments such as food, travel and fees) from 18 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $163.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 12 | $163 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $162 |
| Lilly USA, LLC LLY | 6 | $88.83 |
| Novo Nordisk Inc NVO | 4 | $70.42 |
| Abbvie Inc. ABBV | 4 | $62.39 |
| Ardelyx, Inc. ARDX | 2 | $52.06 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $46.4 |
| GlaxoSmithKline, LLC. GSK | 2 | $28.39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $26.08 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $24.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.